cGxP.wire https://validator.w3.org/feed/docs/rss2.html Sera Applauds Illinois Medicaid Coverage for PreTRM Blood Test Mabwell Receives China IND Clearance for 6MW5311 Cancer Therapy Abbisko Therapeutics and Lilly Expand Global R&D Partnership Cognivia and Mayo Clinic Partner to Improve Clinical Research Outcomes Allergan Aesthetics Wins Canada Approval for Boey Neurotoxin AbbVie Secures EU Approval for MAVIRET in Acute Hepatitis C Bridge to Life Showcases VitaSmart HOPE Data at ATC 2026 Ascletis Receives FDA IND Clearance for ASC35 Obesity Trial CereVasc Completes Pivotal STRIDE Trial Enrollment for eShunt Armata Secures $2.5M DoD Funding for AP-SA02 Mediar Starts Phase 1 Trial of MTX-439 in CKD Leal Therapeutics Doses First ALS Patient with LTX-002 Calico Wins FDA Breakthrough Status for Fosigotifator Delphi Diagnostics Validates EAI for Paclitaxel Benefit Hamlet BioPharma Advances Alpha1H into Phase 3 Trial Draeger Receives FDA Clearance for Evita V800 Upgrade Phanes Completes Phase 2 Enrollment for Spevatamig in PDAC Hamlet BioPharma Expands Alpha1H Trial for Bladder Cancer Lys Therapeutics Advances LYS241 with €25M Funding Boost Genprex Strengthens REQORSA Cancer Gene Therapy Patent Pierre Fabre Secures EU Approval for BRAFTOVI in mCRC US WorldMeds Secures Full FDA Approval for TECELRA REGENXBIO Advances NAVSUNLI Toward Accelerated Approval AbbVie to Acquire Apogee in $10.9B Immunology Expansion Murj Expands Cardiac Care Platform Across Australia and NZ MoonLake Reports Strong Phase 3 Sonelokimab HS Results BioArctic, Lilly Partner on Next-Gen Brain Therapies Insilico Medicine and SK Bio Launch $2.5B CNS Alliance Velico Reports Positive Trial Results for FrontlineODP Kyowa Hakko Presents New Evidence Supporting Cognizin’s Cognitive Benefits Mighty Therapeutics Announces New Era in Mitochondrial Medicine CureGene Doses First Patient in Pivotal Evategrel Trial Antengene Signs Up to $1.9 Billion TCE Licensing Deal LOTTE Biologics Completes Songdo Plant 1 Construction INTCO Medical Unveils Advanced Healthcare Solutions at WHX 2026 5W AI Index Reveals New Pharma Visibility Leaders Online Merz Therapeutics and Teijin Secure Japan Approval for XEOMIN® MediThinQ Partners With Synovis to Advance Digital Microsurgery Fapon Biopharma Showcases Dual B-Cell Immunotherapy Platform SOPHiA GENETICS Raises $57.5 Million to Accelerate AI Healthcare Terumo Blood and Cell Technologies Supports New Imara Sickle Cell Framework Avance Clinical Highlights Oncology Expertise at ASCO 2026 Novocure Reports Phase 3 TRIDENT Trial Results CervoMed Secures $10 Million to Advance Brain Disease Pipeline Belay Announces NCCN Recommendation for CSF-Based Profiling in High-Grade Gliomas CareDx Publishes New KOAR Kidney Transplant Data Channel Robotics Raises $4.6M for Endoscopic Robotics iQure Pharma Wins MJFF Grant for Parkinson’s Research cAMPfield Launches With $180M to Advance Oral IBD Therapy Braeburn Presents New BRIXADI Data at CPDD 2026